A PHASE II GROUPWIDE TRIAL OF PRE-IRRADIATION VINCRISTINE, CISPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE CHEMOTHERAPY FOR CHILDREN AGED 3 TO 21 YEARS WITH NEWLY-DIAGNOSED INTRACRANIAL EPENDYMOMA AND RADIOLOGIC EVIDENCE OF POSTOPERATIVE RESIDUAL TUMOR